Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis
Primary Sclerosing Cholangitis (PSC) is a progressive cholestatic liver disease with liver transplantation (LT) as the only curative therapy. Some regions use body-weight-loss as standard-exception criteria for organ allocation but data on the impact of body composition on survival of patients with PSC is scarce.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Michael Praktiknjo, Taotao Zhou, Maximiliane Kr üsken, Torid Jacob, Alois M. Sprinkart, Sebastian Nowak, Markus Kimmann, Leona Dold, Johannes Chang, Christian Jansen, Christian P. Strassburg, Julian Luetkens, Tobias J. Weismüller Tags: Liver, Pancreas and Biliary Tract Source Type: research
More News: Gastroenterology | Liver | Liver Disease | Liver Transplant | Pancreas | Transplant Surgery | Transplants | Urology & Nephrology | Weight Loss